Dry eye. Diseases of the eye and adnexa
Conditions
Interventions
Intervention 1: Intervention group: Artificial tear eye drop, one drop, three times a day for one month+ Green tea eye drop, one drop, three times a day for one month.
For preparation of green tea dr
Treatment - Drugs
Intervention group: Artificial tear eye drop, one drop, three times a day for one month+ Green tea eye drop, one drop, three times a day for one month.
For preparation of green tea drop, we brewed g
Control group: Standard treatment include artificial tear eye drop one drop three times a day for one month.
Sponsors
Shiraz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
30 Years to 70 Years
Inclusion criteria
Inclusion criteria: Incliusion criteria included? Dry eye and meibomian gland dysfunction. Exclusion criteria included? Use of oral tetracyclines and corticosteroids in 3 months before study and all ophthalmic medication in one month before, Patients with other ocular surface disorders such as corneal surface damage, eyelid complications except blepharitis, any previous ocular surgery, history of drug allergy in eye , use of ophthalmic medication to treat other ophthalmic complication except dry eye and blepharitis, severe belepharitis and dry eye that require systemic treatment, Nasolacrimal duct system disorders such as punctal occlusion, Pregnancy and lactation, as well as patients taking systemic medications and systemic diseases affecting this study are excluded.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical symptom. Timepoint: Before the intervention, one month after the intervention. Method of measurement: The questionnaire included: symptoms of itching, Burning, Reduced vision, Foreign body sensation, Pains, photophobia, Redness.;Tear production. Timepoint: Before the intervention, one month after the intervention. Method of measurement: Shirmer test.;Tear film stability. Timepoint: Before the intervention, one month after the intervention. Method of measurement: Tear Film Brake Up Time test.;Ocular surface health. Timepoint: Before the intervention, one month after the intervention. Method of measurement: Staining of the cornea and conjunctiva.;Meibomian glangd safety. Timepoint: Before the intervention, one month after the intervention. Method of measurement: Color and quality of gland secretion. | — |
Secondary
| Measure | Time frame |
|---|---|
| Drug allergy. Timepoint: Before the intervention, one month after the intervention. Method of measurement: Clinical symptom.;Eye infection. Timepoint: Before the intervention, one month after the intervention. Method of measurement: Clinical symptom. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMehdi Zadmehr
Shiraz University of Medical Sciences
Outcome results
None listed